Mycord, a vertical of CelluGen Biotech Pvt. Ltd. has been conferred with ‘Innovation Award’ at the International Conference on ‘Emerging Cellular and Immunotherapies in Haematological Disorders’ held in New Delhi recently.The Innovation award was presented by Indian Society of Cellular Therapy to Mycord for introducing the concept of Family Cord Blood Pool Banking.

Kangan Jaiswal, Director of the company while receiving the award said, “It is our great honor that the medical fraternity of haematologist has recognized our efforts and in doing so have sent the right message to expecting parents that cord blood stem cells are used primarily in allogeneic transplant for most blood disorders.”

Mycord with its expertise in stem cell research has brought to the world the concept of ‘Family Cord Blood Pool banking’. This concept has been a ‘Game Changer’ for the industry to make banked cord blood stem cells enabled for therapy when needed.

This Award was handed over to CelluGen Director Kangan Jaiswal by well-known Doctor in the field of Haematology Oncology,Professor Dr.GhulamJMufti,Head of the Department of haematological medicine at Guy's, King's and St Thomas's hospitals, King's CollegeLondon.

The Innovation award was presented by Indian Society of Cellular Therapy to Mycord for introducing the concept of Family Cord Blood Pool Banking.